Evidence map›Paper›PMID 31934093›Full record

ArticleInternational journal of clinical and experimental pathology2019

miR-373 inhibits nasopharyngeal carcinoma cell migration and invasion by targeting MARCH5.

Zehao Huang, Shengxiao Zhang, Jia Wang, Hehua Sun, Yue Zhang, Xiao Li, Xiang Song

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. MARCH5 promotes aerobic glycolysis to facilitate ovarian cancer progression via ubiquitinating MPC1.Apoptosis : an international journal on programmed cell death · 2024
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Zehao HuangDepartment of Head & Neck Surgery, Cancer Hospital, Peking Union Medical College, Chinese Academy of Medical Science Beijing, P. R. China.
Shengxiao ZhangDepartment of Rheumatology, The Second Hospital of Shanxi Medical University Taiyuan, P. R. China.
Jia WangDepartment of Rheumatology, The Second Hospital of Shanxi Medical University Taiyuan, P. R. China.
Hehua SunDepartment of Rheumatology, The Second Hospital of Shanxi Medical University Taiyuan, P. R. China.
Yue ZhangDepartment of Cardiology, The Second Hospital of Shanxi Medical University Taiyuan, P. R. China.
Xiao LiDepartment of Rheumatology, The Second Hospital of Shanxi Medical University Taiyuan, P. R. China.
Xiang SongDepartment of Oncology, The Second Hospital of Shanxi Medical University Taiyuan, P. R. China.
Shanxi Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The abnormal expression of microRNAs (miRNAs) is critical for the development of human cancers. However, the functions of many miRNAs remain to be elucidated. miR-373 was reported to involve the tumorigenesis of multiple cancers, but its role in nasopharyngeal carcinoma (NPC) is not clear. Quantitative real-time PCR was performed to analyze miR-373 expression in NPC cell lines. The connection between membrane associated ring-CH-type finger 5 (MARCH5) and miR-373 was analyzed using a luciferase activity reporter assay and western blot. A cell counting kit-8 assay, a colony formation assay, and a wound-healing assay were performed to investigate the biological functions of miR-373 and MARCH5. We showed miR-373 expression is downregulated, and MARCH5 expression is upregulated, in NPC cells. MARCH5 was validated as a direct target of miR-373. miR-373 regulates NPC cell proliferation, colony formation, and cell migration by regulating MARCH5. In conclusion, our study showed that miR-373 has a tumor suppressive role in NPC by targeting MARCH5. This may provide novel therapeutic targets for NPC.

Indexed as

growthMARCH5migrationmiR-373nasopharyngeal carcinoma

Identifiers

PMID31934093
PMCPMC6949538
OpenAlexW3026832905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.